IRVINE, Calif.--(EON: Enhanced Online News)--Khang & Khang LLP (the “Firm”) announces that it is investigating claims against Psychemedics Corporation (“Psychemedics” or the “Company”) (Nasdaq: PMD) concerning possible violations of federal securities laws.
“preventing other companies from accessing (the) market.”
If you purchased shares of Psychemedics. and want more information free of charge, please contact Joon M. Khang, Esquire, of Khang & Khang, 18101 Von Karman Avenue, 3rd Floor, Irvine, CA 92612, by telephone: (949) 419-3834, or by e-mail at email@example.com.
On January 31, 2017, it was made public that Psychemedics Brasil Exames Toxicologicos Ltda., Psychemedics' local representative in Brazil, will compensate Omega Laboratories, Inc. USA for losses from anticompetitive practices that are used for "preventing other companies from accessing (the) market.” When this information was released to the public, shares of Psychemedics fell, causing shareholders harm.
If you have any questions concerning this notice or your rights, please contact Joon M. Khang, a prominent litigator for almost two decades, by telephone: (949) 419-3834, or by e-mail at firstname.lastname@example.org.
This press release may constitute Attorney Advertising in some jurisdictions.